NanoViricides Inc.

NanoViricides Inc.
Stock Exchange NYSE
EPS
$0.11
Market Cap
$18.42 M
Shares Outstanding
76.74 M
Public Float
47.23 M

Profile

Address
1 Controls Drive
Shelton Connecticut 06484
United States
Employees -
Website http://www.nanoviricides.com
Updated 07/08/2019
NanoViricides, Inc. is a nano-biopharmaceutical company. The company engages in the discovery, development, and commercialization of therapeutics to advance the care of patients suffering from life-threatening viral infections. It intends to manufacture Injectable and Oral FluCide, HIVCide, Nanoviricide Eye Drops, HerpeCide, DengueCide, RabiCide as well as other drugs for pre-clinical animal studies and human clinical studies.

Financials

View All

Anil R. Diwan
Chairman & President
Stanley Glick
Independent Director